Abstract
Researchers working on opposite coasts of the US have made important progress towards one of the ‘holy grails’ in medicine - the repair of nerve tissue following spinal injury. This week Inpharma takes a look at 2 recent studies that used different approaches and which indicate a potential for treating spinal cord injuries in humans. The first study investigates the experimental use of nerve growth factors in animal models, while in the second study transplantation of embryonic spinal cord cells was carried out in a paralysed man.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
